Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Spinal Cord Compression 1Sarcoma 1Prostatic Neoplasms 1Papillomavirus Infections 1Neoplasms, Unknown Primary 1Melanoma 1Gastrointestinal Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1Adenocarcinoma 1Acquired Immunodeficiency Syndrome 1

Interventions

Magnetic Resonance Spectroscopy 3selpercatinib 2entrectinib 2Specimen Handling 2Interviews as Topic 2trametinib 1omipalisib 1gallium Ga 68 dotatate 1cabozantinib 1X-Rays 1Vemurafenib 1Transurethral Resection of Prostate 1Sodium Iodide 1Postoperative Period 1Phantoms, Imaging 1Nivolumab 1Ipilimumab 1Iodine-131 1Iodine-124 1Decision Support Techniques 1Counseling 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Cancer, Papillary × Transurethral Resection of Prostate × 90 days × Clear all
NCT06316895 2026-03-20

The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma

Chinese PLA General Hospital

Recruiting
3,772 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡